Skip to main content
Log in

Preparation and evaluation of ethylcellulose microcapsules of indomethacin

  • Original Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Indomethacin was microencapsulated with ethylcellulose using a modified spherical agglomeration process, aiming at a sustained release preparation without side effects on the stomach. The surface morphology of the microcapsules was examined using scanning electron microscopy. The microcapsules were porous and spherical, and their porosity increased with increasing the viscosity of ethylcellulose.In vitro dissolution process followed Higuchi’s diffusion model for first 3 hr. Release rate of the drug from microcapsules decreased as the viscosity of ethylcellulose or the weight ratio of indomethacin to ethylcellulose was decreased. The release rate also decreased with increasing the microcapsule size. The microcapsules induced less gastric ulcer in rats than raw drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. O’Brien, W.M.: Indomethacin: a survey of clinical trials.Clin. Pharmacol. Ther. 9, 94(1968).

    PubMed  CAS  Google Scholar 

  2. Smyth, C.J. and Percy, J.S.: Comparison of indomethacin and phenylbutazone in acute gout.Ann. Rheum. Dis. 32: 351(1973).

    Article  PubMed  CAS  Google Scholar 

  3. Kwan, K.C., Breault, G.O., Unbenhauer, E.R., McMahon, F.G. and Duggan, D.E.: The kinetics of indomethacin absorption, elimination and enterohepatic circulation in man.J. Pharmacokinet. Biopharm. 4, 225(1976).

    Google Scholar 

  4. Gillman, A.G., Goodman, L.S. and Gillman, A.:Goodman and Gillman’s The pharmacolgoical basis of therapeutics. 6th ed., Macmillan, 705(1980).

  5. Vane, J.R.: Inhibition of prostaglandin synthesis as a mechanism for aspirin-like drugs.Nature 231, 232(1971).

    CAS  Google Scholar 

  6. Vidras, N.J., Reid, M.J., Bohidar, N.R. and Plakogiannis, F.M.: Medicament release from suppository bases I: Physicochemiacl characteristics and bioavailability of indomethacin in rabbits.J. Pharm. Sci. 71, 945(1982).

    Article  PubMed  CAS  Google Scholar 

  7. Nitto Electric Industrial Co., Ltd.:Jpn. Kokai Tokkyo Koho 81, 40, 608(1981).

    Google Scholar 

  8. Alvan, C., Orme, M., Bertilesson, L., Ekstrand, R. and Palmer, L.: Pharmackinetics of indomethacin.Clin. Pharmacol. Ther. 18, 368(1974).

    Google Scholar 

  9. Shima, K., Matsusaka, C., Hirose, M., Noguchi, T. and Yamahira, Y.: Biopharmaceutical characteristics of indomethacin gel ointment.Chem. Pharm. Bull. 29, 2338 (1981).

    PubMed  CAS  Google Scholar 

  10. Ishiguro, F., Minamiki, A., Kanagawa, T., Kawajiri, A., Ishiguro, J. and Koizumi, T.: Percutaneous absorption of indomethacin from plasters.Yakuzaigaku 42, 324(1928).

    Google Scholar 

  11. Nitto Electric Industrial Co., Ltd.:Jpn. Kokai Tokkyo Koho 81, 51, 412(1981).

    Google Scholar 

  12. Rowe, J.S., and Carless, J.E.: Encapsulation of indomethacin.UK Patent GB 2075458 Nov. 18, (1981).

  13. Dempski, R.E., Mehta, G.N. and Saboe, J.S.: Sustained release indomethacin.U.S. Patent 4173626 Nov. 6, (1979).

  14. Takeda, Y., Nambu, N. and Nagai, T.: Microencapsulation and bioavailability in beagle dogs of indomethacin.Chem. Pharm. Bull. 29, 264 (1981).

    PubMed  CAS  Google Scholar 

  15. Rowe, J.S. and Carless, J.E.: Comparison of thein vitro dissolution behavior of various indomethacin formulations with theirin vivo bioavailability.J. Pharm. Pharmacol. 33, 561(1981).

    PubMed  CAS  Google Scholar 

  16. Mizushima, Y., Wada, Y., Etoh, Y. and Watanabe, K.: Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere.J. Pharm. Pharmacol. 35, 398(1983).

    PubMed  CAS  Google Scholar 

  17. Eckenhoff, B., Theeuwes, F. and Urquhart, J.: Osmotically actuated dosage forms for rate controlled drug delivery.Pharmaceutical Technology Jan, 35(1981).

    Google Scholar 

  18. Bertouch, J.V., Harrington, B. and Brooks, P.M.: Pharmacokinetics of an osmotically controlled delivery indomethacin preparation in normal volunteers.Clin. Exp. Pharmacol. 10, 411(1983).

    Article  CAS  Google Scholar 

  19. Kawashima, Y., Ohno, H. and Takenaka, H., Preparation of spherical matrices of prolonged release drugs from liquid suspension.J. Pharm. Sci. 70, 913(1981).

    Article  PubMed  CAS  Google Scholar 

  20. Satoh, H., Guth, P.H. and Grossman, M.I.: Role of food in gastrointestinal ulceration produced by indomethacin in the rat.Gastroenterology 83, 210(1982).

    PubMed  CAS  Google Scholar 

  21. Kawashima, Y. and Capes, C.E.: Further studies of spherical agglomeration in a stirred vessel.Powder Technology 13, 279(1976).

    Article  CAS  Google Scholar 

  22. Deasy, P.B., Brophy, M.R., Ecanow, B. and Joy, M.: Effect of ethylcellulose grade and sealant treatments on the production andin vitro release of microencapsulated sodium salicylated.J. Pharm. Pharmacol. 32, 15(1980).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

A part of this work is taken from a dissertation submitted by H.J. Lee to the Graduate School, College of Pharmacy, Seoul National University, Seoul, Korea, in partial fulfillment of the requirements for the degree of Master of Science.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, HJ., Lee, MH. & Shim, CK. Preparation and evaluation of ethylcellulose microcapsules of indomethacin. Arch. Pharm. Res. 7, 33–40 (1984). https://doi.org/10.1007/BF02856919

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02856919

Keywords

Navigation